董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Jiong Ma | 女 | Chief Executive Officer, President and Director | 57 | 未披露 | 未持股 | 2021-07-19 |
| Andre Jacques Auberton Herve | 男 | Chairman of the Board | 59 | 未披露 | 未持股 | 2021-07-19 |
| Karen Kerr | 女 | Director | 52 | 未披露 | 未持股 | 2021-07-19 |
| Bernhard Stapp | 男 | Director | 65 | 未披露 | 未持股 | 2021-07-19 |
| Patrick J. Ennis | 男 | Director | 57 | 未披露 | 未持股 | 2021-07-19 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Jiong Ma | 女 | Chief Executive Officer, President and Director | 57 | 未披露 | 未持股 | 2021-07-19 |
| Michael Lee | 男 | Chief Financial Officer | 45 | 未披露 | 未持股 | 2021-07-19 |
董事简历
中英对照 | 中文 | 英文- Jiong Ma
-
Jiong Ma自2021年3月起担任我们的首席执行官兼总裁。自2020年11月以来，马博士一直是Braemar Energy Ventures“；Braemar”；（一家专注于能源的风险投资公司）的风险合伙人。从2008年到2020年10月，马博士担任Braemar的高级合伙人和投资委员会成员。在Braemar任职期间，马云带领投资了超过15家涉及资源效率、电子移动、工业数字化、可再生能源或深度科技的公司，并通过并购和IPO实现了多次成功退出。在她的职业生涯中，她在10多家风险投资公司的董事会任职，包括Powervation（被Rohm Semiconductor Ltd.收购）、Convery Computer（被美光科技公司收购）、MC10（被Medidata收购）和Carbonite Inc.，该公司于2011年上市，随后于2019年被OpenText（NASDAQ:OTEX）以14.5亿美元收购。马博士目前在Anavex Life SciencesCorp.（NASDAQ:AVXL）的董事会任职，并担任DeMeter Partners的顾问委员会成员，DeMeter Partners是一家致力于欧洲生态和能源转型的VC/PE基金，以及国家可再生能源实验室，美国能源部的一个国家实验室，负责开发转换能源的产生、消耗、储存和分配的解决方案。从2004年到2008年，马博士是3i（一家全球私人股本公司）风险投资部门的投资专家，在那里她领导了技术和媒体、数字健康和清洁技术的多个阶段的投资。从1997年到2004年，她在Lucent Technologies和Nortel Networks担任多个高级职位，在那里她负责投资组合战略、产品开发和研究与开发。2000年，马博士联合创立了Onetta Inc.，这是一家光学网络公司，该公司于2004年被Bookham Technology收购。马博士拥有科罗拉多大学博尔德分校电气和计算机工程博士学位，沃切斯特理工学院电气工程硕士学位，中国兰州大学物理和电气工程学士学位。马博士也是考夫曼的研究员。
Jiong Ma,has over 25 years of experience in the investing, building and scaling of companies with a focus on innovative product launches in digital health, technology and the new energy transition. Dr. Ma currently serves on the board of SES AI Corporation (NYSE: SES), and LinkinVax, a biotech company, spin-off from the Vaccine Research Institute in France. Dr. Ma served as senior partner and a member of the investment committee at Braemar Energy Ventures ("Braemar"). While at Braemar, Dr. Ma led investments in more than 15 companies involved in either resource efficiency, e-mobility, industrial digitalization, renewable energy, or deep tech, and has achieved multiple successful exits through M&A and IPO. Dr. Ma has significant knowledge and expertise in the technology industry, including information security. Prior to Braemar Energy Ventures, she was with the Venture Capital Group at 3i Group, a global private equity firm, where she led investments across multiple stages in Digital Health, TMT and Cleantech. Preceding the Venture Capital Group at 3i, Dr. Ma held several senior positions at Lucent Technologies and Bell Labs. Her responsibilities included lead roles in product portfolio strategy, new product launches for Optical and Data Networking, and research and product development. Dr. Ma was also a founding team member of Onetta Inc., a fiber networks company. She has a PhD in Electrical and Computer Engineering from the University Colorado at Boulder and an MS in Electrical Engineering from Worcester Polytechnic Institute. Dr. Ma is a Kauffman Fellow. - Jiong Ma自2021年3月起担任我们的首席执行官兼总裁。自2020年11月以来，马博士一直是Braemar Energy Ventures“；Braemar”；（一家专注于能源的风险投资公司）的风险合伙人。从2008年到2020年10月，马博士担任Braemar的高级合伙人和投资委员会成员。在Braemar任职期间，马云带领投资了超过15家涉及资源效率、电子移动、工业数字化、可再生能源或深度科技的公司，并通过并购和IPO实现了多次成功退出。在她的职业生涯中，她在10多家风险投资公司的董事会任职，包括Powervation（被Rohm Semiconductor Ltd.收购）、Convery Computer（被美光科技公司收购）、MC10（被Medidata收购）和Carbonite Inc.，该公司于2011年上市，随后于2019年被OpenText（NASDAQ:OTEX）以14.5亿美元收购。马博士目前在Anavex Life SciencesCorp.（NASDAQ:AVXL）的董事会任职，并担任DeMeter Partners的顾问委员会成员，DeMeter Partners是一家致力于欧洲生态和能源转型的VC/PE基金，以及国家可再生能源实验室，美国能源部的一个国家实验室，负责开发转换能源的产生、消耗、储存和分配的解决方案。从2004年到2008年，马博士是3i（一家全球私人股本公司）风险投资部门的投资专家，在那里她领导了技术和媒体、数字健康和清洁技术的多个阶段的投资。从1997年到2004年，她在Lucent Technologies和Nortel Networks担任多个高级职位，在那里她负责投资组合战略、产品开发和研究与开发。2000年，马博士联合创立了Onetta Inc.，这是一家光学网络公司，该公司于2004年被Bookham Technology收购。马博士拥有科罗拉多大学博尔德分校电气和计算机工程博士学位，沃切斯特理工学院电气工程硕士学位，中国兰州大学物理和电气工程学士学位。马博士也是考夫曼的研究员。
- Jiong Ma,has over 25 years of experience in the investing, building and scaling of companies with a focus on innovative product launches in digital health, technology and the new energy transition. Dr. Ma currently serves on the board of SES AI Corporation (NYSE: SES), and LinkinVax, a biotech company, spin-off from the Vaccine Research Institute in France. Dr. Ma served as senior partner and a member of the investment committee at Braemar Energy Ventures ("Braemar"). While at Braemar, Dr. Ma led investments in more than 15 companies involved in either resource efficiency, e-mobility, industrial digitalization, renewable energy, or deep tech, and has achieved multiple successful exits through M&A and IPO. Dr. Ma has significant knowledge and expertise in the technology industry, including information security. Prior to Braemar Energy Ventures, she was with the Venture Capital Group at 3i Group, a global private equity firm, where she led investments across multiple stages in Digital Health, TMT and Cleantech. Preceding the Venture Capital Group at 3i, Dr. Ma held several senior positions at Lucent Technologies and Bell Labs. Her responsibilities included lead roles in product portfolio strategy, new product launches for Optical and Data Networking, and research and product development. Dr. Ma was also a founding team member of Onetta Inc., a fiber networks company. She has a PhD in Electrical and Computer Engineering from the University Colorado at Boulder and an MS in Electrical Engineering from Worcester Polytechnic Institute. Dr. Ma is a Kauffman Fellow.
- Andre Jacques Auberton Herve
-
在本次发行完成后，Andre Jacques Auberton Herve将担任我们的董事会主席。Auberton-Herv博士担任Soitec的名誉主席，Soitec是一家市值超过60亿美元的绝缘子上硅SOI技术的领导者，也是CAC MID60指数的成分股公司，他于1992年从一个政府实验室联合创立了这家公司，并于1999年在巴黎的泛欧交易所上市。从1992年7月到2015年1月，担任Soitec’；的总裁兼首席执行官23年，Auberton-Herv博士负责监督该公司的战略、运营和财务活动，该公司跨越10个国家，在欧洲拥有5个制造设施，Auberton-Herve博士是4A Consulting&Engineering的创始人，该公司提供可再生能源和数字创新方面的战略咨询和咨询服务，自2015年7月成立以来担任总裁兼首席执行官。2016年，他成为C4Ventures的运营合伙人，这是一家领先的欧洲风险投资基金，由Pascal Cagni（副总裁兼总经理，苹果公司，2000年至2012年）创立。2018年2月，他创立了他管理的公司ATAJ，担任法国领先的风险投资基金Sofinnova Partners及其Sofinnova IT FPCI基金的顾问。Auberton-Herv博士自2018年1月起担任Bionik LaboratoriesCorp.董事会主席2013年，Auberton-Herv博士当选为Semi国际董事会主席，Semi是代表电子制造业的卓越的全球工业协会。Auberton-Herv博士是众多行业奖项的获得者，包括法国总统雅克·希拉克颁发的大胆创新奖和欧洲工商管理学院企业家奖。Auberton-Herv博士拥有里昂中央大学物理学博士学位。他也是法国荣誉军团的骑士和法国国家勋章获得者。
Andre Jacques Auberton Herve will serve as the Chairman of our board of directors following the completion of this offering. Dr. Auberton-Hervé serves as Chairman Emeritus of Soitec, a leader in Silicon-On-Insulator SOI technologies with a market capitalization of over $6 billion and a constituent company in the CAC Mid 60 Index, which he co-founded in 1992 out of a government laboratory and took public in Paris on the Euronext Stock Exchange in 1999. Serving for 23 years as Soitec’s President and Chief Executive Officer from July 1992 to January 2015 Dr. Auberton-Hervé was responsible for overseeing the company’s strategic, operational and financial activities that spanned across ten countries with five manufacturing facilities in Europe, Asia and the U.S. Dr. Auberton-Herve is the founder of 4A Consulting & Engineering, which provides strategic advice and consulting services with respect to renewable energy and digital innovation, and has served as its President and CEO since its founding in July 2015. In 2016 he became an operating partner of C4 Ventures, a leading European venture capital fund founded by Pascal Cagni (VP & GM EMEIA, Apple Inc., 2000-2012). In February 2018 he founded ATAJ, a company that he manages and that operates as advisor to Sofinnova Partners, a leading French venture capital fund, and its Sofinnova IT FPCI fund. Since January 2018 Dr. Auberton-Hervé has served as Chairman of the board of Bionik Laboratories Corp. In 2013 Dr. Auberton-Hervé was elected as Chairman of International Board of Directors of SEMI, the preeminent global industry association representing the electronics manufacturing industries. Dr. Auberton-Hervé is a recipient of numerous industry accolades, including the Audacity in Creativity Award from French President Jacques Chirac and the INSEAD Entrepreneurship Prize. Dr. Auberton-Hervé holds a doctorate degree with distinction in Physics from Ecole Centrale de Lyon. He is also a knight of the French Legion d’Honneur and the Ordre national du Mérite. - 在本次发行完成后，Andre Jacques Auberton Herve将担任我们的董事会主席。Auberton-Herv博士担任Soitec的名誉主席，Soitec是一家市值超过60亿美元的绝缘子上硅SOI技术的领导者，也是CAC MID60指数的成分股公司，他于1992年从一个政府实验室联合创立了这家公司，并于1999年在巴黎的泛欧交易所上市。从1992年7月到2015年1月，担任Soitec’；的总裁兼首席执行官23年，Auberton-Herv博士负责监督该公司的战略、运营和财务活动，该公司跨越10个国家，在欧洲拥有5个制造设施，Auberton-Herve博士是4A Consulting&Engineering的创始人，该公司提供可再生能源和数字创新方面的战略咨询和咨询服务，自2015年7月成立以来担任总裁兼首席执行官。2016年，他成为C4Ventures的运营合伙人，这是一家领先的欧洲风险投资基金，由Pascal Cagni（副总裁兼总经理，苹果公司，2000年至2012年）创立。2018年2月，他创立了他管理的公司ATAJ，担任法国领先的风险投资基金Sofinnova Partners及其Sofinnova IT FPCI基金的顾问。Auberton-Herv博士自2018年1月起担任Bionik LaboratoriesCorp.董事会主席2013年，Auberton-Herv博士当选为Semi国际董事会主席，Semi是代表电子制造业的卓越的全球工业协会。Auberton-Herv博士是众多行业奖项的获得者，包括法国总统雅克·希拉克颁发的大胆创新奖和欧洲工商管理学院企业家奖。Auberton-Herv博士拥有里昂中央大学物理学博士学位。他也是法国荣誉军团的骑士和法国国家勋章获得者。
- Andre Jacques Auberton Herve will serve as the Chairman of our board of directors following the completion of this offering. Dr. Auberton-Hervé serves as Chairman Emeritus of Soitec, a leader in Silicon-On-Insulator SOI technologies with a market capitalization of over $6 billion and a constituent company in the CAC Mid 60 Index, which he co-founded in 1992 out of a government laboratory and took public in Paris on the Euronext Stock Exchange in 1999. Serving for 23 years as Soitec’s President and Chief Executive Officer from July 1992 to January 2015 Dr. Auberton-Hervé was responsible for overseeing the company’s strategic, operational and financial activities that spanned across ten countries with five manufacturing facilities in Europe, Asia and the U.S. Dr. Auberton-Herve is the founder of 4A Consulting & Engineering, which provides strategic advice and consulting services with respect to renewable energy and digital innovation, and has served as its President and CEO since its founding in July 2015. In 2016 he became an operating partner of C4 Ventures, a leading European venture capital fund founded by Pascal Cagni (VP & GM EMEIA, Apple Inc., 2000-2012). In February 2018 he founded ATAJ, a company that he manages and that operates as advisor to Sofinnova Partners, a leading French venture capital fund, and its Sofinnova IT FPCI fund. Since January 2018 Dr. Auberton-Hervé has served as Chairman of the board of Bionik Laboratories Corp. In 2013 Dr. Auberton-Hervé was elected as Chairman of International Board of Directors of SEMI, the preeminent global industry association representing the electronics manufacturing industries. Dr. Auberton-Hervé is a recipient of numerous industry accolades, including the Audacity in Creativity Award from French President Jacques Chirac and the INSEAD Entrepreneurship Prize. Dr. Auberton-Hervé holds a doctorate degree with distinction in Physics from Ecole Centrale de Lyon. He is also a knight of the French Legion d’Honneur and the Ordre national du Mérite.
- Karen Kerr
-
Karen Kerr将在本次发行完成后担任董事。Kerr博士拥有超过25年的风险投资和技术投资经验。2019年5月，Kerr博士创立了Exposition Ventures，这是一家风险投资公司，她也担任董事总经理。从2014年4月到2019年4月，她担任GE Ventures的执行董事总经理，领导先进制造、供应链技术、物流和企业软件的投资。1996年至2005年间，她曾担任Arch Venture Partners的董事总经理，在那里她帮助将管理的资产增加到10亿美元以上。科尔博士曾担任Intellectual Ventures的董事，以及南加州大学（University of Southern California）New Ventures和Alliances的高级董事。Kerr博士的职业生涯始于Patricof&Co.，是考夫曼研究员特许课程的一员。科尔博士活跃于多个董事会，包括考夫曼研究员，MHUB，ORAU，清洁能源信托基金和布林莫尔学院董事会。Kerr博士在芝加哥大学物理科学系和分子工程研究所咨询委员会任职。此前，科尔博士曾担任美国国家科学基金会（National Science Foundation）的小企业创新研究计划咨询委员会成员，以及美国国家标准与技术研究所（National Institute for Standards and Technology）的先进技术访问委员会成员。科尔博士在芝加哥大学获得物理化学博士学位，在布林莫尔学院获得化学学士学位。科尔博士被公认为企业风险投资的新星，芝加哥商业科技50强，洛杉矶最顶尖的创新者之一，芝加哥40岁以下的商界领袖和C200女性商界领袖。
Karen Kerr will serve as a director following the completion of this offering. Dr. Kerr has over 25 years of experience in venture capital and technology investing. In May 2019 Dr. Kerr founded Exposition Ventures, a venture capital firm where she also serves as Managing Director. From April 2014 to April 2019 Dr. Kerr served as Executive Managing Director at GE Ventures, where she led investments in advanced manufacturing, supply chain technology, logistics, and enterprise software. Between 1996 and 2005 Dr. Kerr was a Managing Director at ARCH Venture Partners, where she helped grow assets under management to over $1 billion. Dr. Kerr has served as a director at Intellectual Ventures, and Senior Director of New Ventures and Alliances at the University of Southern California. Dr. Kerr started her career at Patricof & Co. and is a member of the Charter Class of Kauffman Fellows. Dr. Kerr is active on multiple boards, including the Kauffman Fellows, mHub, ORAU, the Clean Energy Trust and the Bryn Mawr College Board of Trustees. Dr. Kerr serves on the University of Chicago Physical Sciences Division and the Institute of Molecular Engineering Advisory Committees. Previously, Dr. Kerr served on the National Science Foundation’s Advisory Committee for the Small Business Innovative Research Program and on the National Institute for Standards and Technologies Visiting Committee on Advanced Technologies. Dr. Kerr earned a Ph.D. in Physical Chemistry from the University of Chicago and an A.B. in Chemistry from Bryn Mawr College. Dr. Kerr has been recognized as a Corporate Venture Capital Rising Star, a Crain’s Chicago Business Tech 50 one of LA’s Top Innovators, Crain’s Chicago Business 40 Under 40 and C200 Women Business Leaders. - Karen Kerr将在本次发行完成后担任董事。Kerr博士拥有超过25年的风险投资和技术投资经验。2019年5月，Kerr博士创立了Exposition Ventures，这是一家风险投资公司，她也担任董事总经理。从2014年4月到2019年4月，她担任GE Ventures的执行董事总经理，领导先进制造、供应链技术、物流和企业软件的投资。1996年至2005年间，她曾担任Arch Venture Partners的董事总经理，在那里她帮助将管理的资产增加到10亿美元以上。科尔博士曾担任Intellectual Ventures的董事，以及南加州大学（University of Southern California）New Ventures和Alliances的高级董事。Kerr博士的职业生涯始于Patricof&Co.，是考夫曼研究员特许课程的一员。科尔博士活跃于多个董事会，包括考夫曼研究员，MHUB，ORAU，清洁能源信托基金和布林莫尔学院董事会。Kerr博士在芝加哥大学物理科学系和分子工程研究所咨询委员会任职。此前，科尔博士曾担任美国国家科学基金会（National Science Foundation）的小企业创新研究计划咨询委员会成员，以及美国国家标准与技术研究所（National Institute for Standards and Technology）的先进技术访问委员会成员。科尔博士在芝加哥大学获得物理化学博士学位，在布林莫尔学院获得化学学士学位。科尔博士被公认为企业风险投资的新星，芝加哥商业科技50强，洛杉矶最顶尖的创新者之一，芝加哥40岁以下的商界领袖和C200女性商界领袖。
- Karen Kerr will serve as a director following the completion of this offering. Dr. Kerr has over 25 years of experience in venture capital and technology investing. In May 2019 Dr. Kerr founded Exposition Ventures, a venture capital firm where she also serves as Managing Director. From April 2014 to April 2019 Dr. Kerr served as Executive Managing Director at GE Ventures, where she led investments in advanced manufacturing, supply chain technology, logistics, and enterprise software. Between 1996 and 2005 Dr. Kerr was a Managing Director at ARCH Venture Partners, where she helped grow assets under management to over $1 billion. Dr. Kerr has served as a director at Intellectual Ventures, and Senior Director of New Ventures and Alliances at the University of Southern California. Dr. Kerr started her career at Patricof & Co. and is a member of the Charter Class of Kauffman Fellows. Dr. Kerr is active on multiple boards, including the Kauffman Fellows, mHub, ORAU, the Clean Energy Trust and the Bryn Mawr College Board of Trustees. Dr. Kerr serves on the University of Chicago Physical Sciences Division and the Institute of Molecular Engineering Advisory Committees. Previously, Dr. Kerr served on the National Science Foundation’s Advisory Committee for the Small Business Innovative Research Program and on the National Institute for Standards and Technologies Visiting Committee on Advanced Technologies. Dr. Kerr earned a Ph.D. in Physical Chemistry from the University of Chicago and an A.B. in Chemistry from Bryn Mawr College. Dr. Kerr has been recognized as a Corporate Venture Capital Rising Star, a Crain’s Chicago Business Tech 50 one of LA’s Top Innovators, Crain’s Chicago Business 40 Under 40 and C200 Women Business Leaders.
- Bernhard Stapp
-
本次发行完成后，Bernhard Stapp将担任董事。Bernhard Stapp博士自2011年11月起担任CS-Management GmbH的总裁，该公司为专注于LED、OLED、光子、清洁技术和电子材料的公司和投资公司提供咨询和咨询服务。从2009年到2011年，Stapp博士担任Osram Licht AG（光学和LED技术的全球领导者）的固态照明高级副总裁。从2001年到2009年，Stapp博士在Osram Opto Semiconductors AG担任多个职位，包括LED和OLED组件的首席技术官和总经理。Stapp博士在Siemens AG开始他的职业生涯，在那里他的角色包括材料和制造主管，功能薄膜的集团领导者，以及光纤，紫外和超声波部门的高级科学家。斯塔普博士在德国乌尔姆大学获得金属有机物博士学位和化学学士学位。
Bernhard Stapp will serve as a director following the completion of this offering. Dr. Bernhard Stapp has served as President of CS-management GmbH, which provides consulting and advisory services to companies and investment firms with a focus on LED, OLED, photonics, cleantech and electronics materials, since November 2011. Between 2009 and 2011 Dr. Stapp served as Senior Vice President of Solid-State Lighting at OSRAM Licht AG, a global leader in optics and LED technology. Between 2001 and 2009 Dr. Stapp served in numerous roles at OSRAM Opto Semiconductors AG, including Chief Technology Officer and General Manager for LED and OLED components. Dr. Stapp began his career at Siemens AG where his roles included Head of Materials and Manufacturing, Group Leader of Functional Thin Films, and roles as Senior Scientist within the optical fiber, UV and ultrasound divisions. Dr. Stapp earned a Ph.D. in Metal Organics and a BS in Chemistry from the University Ulm in Germany. - 本次发行完成后，Bernhard Stapp将担任董事。Bernhard Stapp博士自2011年11月起担任CS-Management GmbH的总裁，该公司为专注于LED、OLED、光子、清洁技术和电子材料的公司和投资公司提供咨询和咨询服务。从2009年到2011年，Stapp博士担任Osram Licht AG（光学和LED技术的全球领导者）的固态照明高级副总裁。从2001年到2009年，Stapp博士在Osram Opto Semiconductors AG担任多个职位，包括LED和OLED组件的首席技术官和总经理。Stapp博士在Siemens AG开始他的职业生涯，在那里他的角色包括材料和制造主管，功能薄膜的集团领导者，以及光纤，紫外和超声波部门的高级科学家。斯塔普博士在德国乌尔姆大学获得金属有机物博士学位和化学学士学位。
- Bernhard Stapp will serve as a director following the completion of this offering. Dr. Bernhard Stapp has served as President of CS-management GmbH, which provides consulting and advisory services to companies and investment firms with a focus on LED, OLED, photonics, cleantech and electronics materials, since November 2011. Between 2009 and 2011 Dr. Stapp served as Senior Vice President of Solid-State Lighting at OSRAM Licht AG, a global leader in optics and LED technology. Between 2001 and 2009 Dr. Stapp served in numerous roles at OSRAM Opto Semiconductors AG, including Chief Technology Officer and General Manager for LED and OLED components. Dr. Stapp began his career at Siemens AG where his roles included Head of Materials and Manufacturing, Group Leader of Functional Thin Films, and roles as Senior Scientist within the optical fiber, UV and ultrasound divisions. Dr. Stapp earned a Ph.D. in Metal Organics and a BS in Chemistry from the University Ulm in Germany.
- Patrick J. Ennis
-
PatrickJ.Ennis将在本次发行完成后担任董事。Patrick Ennis博士拥有超过30年的科学家、工程师、商人和风险投资家的经验。自2019年4月以来，Ennis博士一直担任Madrona Venture Group的风险合伙人，这是一家专注于早期科技公司的风险投资和私募股权集团。自2016年4月以来，Ennis博士一直担任Wipro Limited NYSE:WIT的董事，这是一家全球信息技术、咨询和业务流程服务公司。从2008年到2019年3月，Ennis博士担任Intellectual Ventures（一家专门从事发明的私募股权公司）的全球技术主管，在那里他负责孵化、种子投资和技术商业化，并主要负责亚洲的投资。2016年1月，Ennis博士担任全球创新市场网络先驱Xinova的联合创始首席技术官，并从成立到2019年3月担任其首席技术官。从1998年6月到2008年3月，他是Arch Venture Partners（一家早期风险投资公司）的董事总经理，在那里他领导种子和早期投资。他领导公司在Impinj（NASDAQ:PI）和Innovalight（被杜邦公司收购）的投资。在他的职业生涯中，他曾任职超过20家风险投资支持公司的董事会，包括Impinj，InnoValight，Kotura（被Mellanox收购）和Artificial Musk（被Bayer Material Science收购）。在加入Arch Venture Partners之前，他曾在Lucent Technologies、AT&T和Bell Labs担任职位，领导软件开发、语音识别、网络设计和运营的工程项目。在贝尔实验室之前，恩尼斯博士在北美和欧洲的国家和政府实验室进行了七年的核物理研究。Ennis博士目前是波托马克研究所的研究员，赫尔辛基大学商业化咨询委员会的成员，私人全球网络安全公司CybeReason的咨询委员会成员，以及国防工业多家公司的顾问。恩尼斯博士在耶鲁大学获得物理学博士学位和硕士学位，在沃顿商学院获得工商管理硕士学位，在威廉与玛丽学院获得数学和物理学学士学位，在那里他被选为Phi Beta Kappa。恩尼斯博士是考夫曼大学的研究员。
Patrick J. Ennis will serve as a director following the completion of this offering. Dr. Patrick Ennis has over 30 years of experience as a scientist, engineer, businessman and venture capitalist. Since April 2019 Dr. Ennis has been a Venture Partner at Madrona Venture Group, a venture capital and private equity group focused on early-stage technology companies. Since April 2016 Dr. Ennis has served as a Director at Wipro Limited NYSE: WIT, a global information technology, consulting and business process services company. From 2008 to March 2019 Dr. Ennis served as Global Head of Technology at Intellectual Ventures, a private equity firm specializing in invention, where he had responsibility for incubation, seed investments and technology commercialization, along with primary responsibility for investments in Asia. In January 2016 Dr. Ennis was the co-founding CTO of Xinova, a pioneer in global innovation market networks, and served as its CTO from inception to March 2019. From June 1998 to March 2008 Dr. Ennis was a Managing Director of ARCH Venture Partners, an early-stage venture firm, where he led seed and early-stage investments. He led the firm’s investments in Impinj (Nasdaq: PI) and Innovalight (acquired by DuPont). During his career, he has served on the boards of more than 20 venture-backed companies including Impinj, Innovalight, Kotura (acquired by Mellanox) and Artificial Muscle (acquired by Bayer Material Science). Prior to joining ARCH Venture Partners, Dr. Ennis held positions with Lucent Technologies, AT&T, and Bell Labs, where he led engineering projects for software development, speech recognition, network design and operations. Prior to Bell Labs, Dr. Ennis conducted research in Nuclear Physics at national and government laboratories in North America and Europe for seven years. Dr. Ennis is currently a Fellow at the Potomac Institute, a member of the University of Helsinki’s Commercialization Advisory Board, a member of the advisory board of Cybereason, a private global cybersecurity company, and an advisor to various companies in the defense industry. Dr. Ennis earned a Ph.D. and MS in Physics from Yale, an MBA from Wharton, and a BS in Math and Physics from the College of William & Mary where he was elected to Phi Beta Kappa. Dr. Ennis is a Kaufman Fellow. - PatrickJ.Ennis将在本次发行完成后担任董事。Patrick Ennis博士拥有超过30年的科学家、工程师、商人和风险投资家的经验。自2019年4月以来，Ennis博士一直担任Madrona Venture Group的风险合伙人，这是一家专注于早期科技公司的风险投资和私募股权集团。自2016年4月以来，Ennis博士一直担任Wipro Limited NYSE:WIT的董事，这是一家全球信息技术、咨询和业务流程服务公司。从2008年到2019年3月，Ennis博士担任Intellectual Ventures（一家专门从事发明的私募股权公司）的全球技术主管，在那里他负责孵化、种子投资和技术商业化，并主要负责亚洲的投资。2016年1月，Ennis博士担任全球创新市场网络先驱Xinova的联合创始首席技术官，并从成立到2019年3月担任其首席技术官。从1998年6月到2008年3月，他是Arch Venture Partners（一家早期风险投资公司）的董事总经理，在那里他领导种子和早期投资。他领导公司在Impinj（NASDAQ:PI）和Innovalight（被杜邦公司收购）的投资。在他的职业生涯中，他曾任职超过20家风险投资支持公司的董事会，包括Impinj，InnoValight，Kotura（被Mellanox收购）和Artificial Musk（被Bayer Material Science收购）。在加入Arch Venture Partners之前，他曾在Lucent Technologies、AT&T和Bell Labs担任职位，领导软件开发、语音识别、网络设计和运营的工程项目。在贝尔实验室之前，恩尼斯博士在北美和欧洲的国家和政府实验室进行了七年的核物理研究。Ennis博士目前是波托马克研究所的研究员，赫尔辛基大学商业化咨询委员会的成员，私人全球网络安全公司CybeReason的咨询委员会成员，以及国防工业多家公司的顾问。恩尼斯博士在耶鲁大学获得物理学博士学位和硕士学位，在沃顿商学院获得工商管理硕士学位，在威廉与玛丽学院获得数学和物理学学士学位，在那里他被选为Phi Beta Kappa。恩尼斯博士是考夫曼大学的研究员。
- Patrick J. Ennis will serve as a director following the completion of this offering. Dr. Patrick Ennis has over 30 years of experience as a scientist, engineer, businessman and venture capitalist. Since April 2019 Dr. Ennis has been a Venture Partner at Madrona Venture Group, a venture capital and private equity group focused on early-stage technology companies. Since April 2016 Dr. Ennis has served as a Director at Wipro Limited NYSE: WIT, a global information technology, consulting and business process services company. From 2008 to March 2019 Dr. Ennis served as Global Head of Technology at Intellectual Ventures, a private equity firm specializing in invention, where he had responsibility for incubation, seed investments and technology commercialization, along with primary responsibility for investments in Asia. In January 2016 Dr. Ennis was the co-founding CTO of Xinova, a pioneer in global innovation market networks, and served as its CTO from inception to March 2019. From June 1998 to March 2008 Dr. Ennis was a Managing Director of ARCH Venture Partners, an early-stage venture firm, where he led seed and early-stage investments. He led the firm’s investments in Impinj (Nasdaq: PI) and Innovalight (acquired by DuPont). During his career, he has served on the boards of more than 20 venture-backed companies including Impinj, Innovalight, Kotura (acquired by Mellanox) and Artificial Muscle (acquired by Bayer Material Science). Prior to joining ARCH Venture Partners, Dr. Ennis held positions with Lucent Technologies, AT&T, and Bell Labs, where he led engineering projects for software development, speech recognition, network design and operations. Prior to Bell Labs, Dr. Ennis conducted research in Nuclear Physics at national and government laboratories in North America and Europe for seven years. Dr. Ennis is currently a Fellow at the Potomac Institute, a member of the University of Helsinki’s Commercialization Advisory Board, a member of the advisory board of Cybereason, a private global cybersecurity company, and an advisor to various companies in the defense industry. Dr. Ennis earned a Ph.D. and MS in Physics from Yale, an MBA from Wharton, and a BS in Math and Physics from the College of William & Mary where he was elected to Phi Beta Kappa. Dr. Ennis is a Kaufman Fellow.
高管简历
中英对照 | 中文 | 英文- Jiong Ma
Jiong Ma自2021年3月起担任我们的首席执行官兼总裁。自2020年11月以来，马博士一直是Braemar Energy Ventures“；Braemar”；（一家专注于能源的风险投资公司）的风险合伙人。从2008年到2020年10月，马博士担任Braemar的高级合伙人和投资委员会成员。在Braemar任职期间，马云带领投资了超过15家涉及资源效率、电子移动、工业数字化、可再生能源或深度科技的公司，并通过并购和IPO实现了多次成功退出。在她的职业生涯中，她在10多家风险投资公司的董事会任职，包括Powervation（被Rohm Semiconductor Ltd.收购）、Convery Computer（被美光科技公司收购）、MC10（被Medidata收购）和Carbonite Inc.，该公司于2011年上市，随后于2019年被OpenText（NASDAQ:OTEX）以14.5亿美元收购。马博士目前在Anavex Life SciencesCorp.（NASDAQ:AVXL）的董事会任职，并担任DeMeter Partners的顾问委员会成员，DeMeter Partners是一家致力于欧洲生态和能源转型的VC/PE基金，以及国家可再生能源实验室，美国能源部的一个国家实验室，负责开发转换能源的产生、消耗、储存和分配的解决方案。从2004年到2008年，马博士是3i（一家全球私人股本公司）风险投资部门的投资专家，在那里她领导了技术和媒体、数字健康和清洁技术的多个阶段的投资。从1997年到2004年，她在Lucent Technologies和Nortel Networks担任多个高级职位，在那里她负责投资组合战略、产品开发和研究与开发。2000年，马博士联合创立了Onetta Inc.，这是一家光学网络公司，该公司于2004年被Bookham Technology收购。马博士拥有科罗拉多大学博尔德分校电气和计算机工程博士学位，沃切斯特理工学院电气工程硕士学位，中国兰州大学物理和电气工程学士学位。马博士也是考夫曼的研究员。
Jiong Ma,has over 25 years of experience in the investing, building and scaling of companies with a focus on innovative product launches in digital health, technology and the new energy transition. Dr. Ma currently serves on the board of SES AI Corporation (NYSE: SES), and LinkinVax, a biotech company, spin-off from the Vaccine Research Institute in France. Dr. Ma served as senior partner and a member of the investment committee at Braemar Energy Ventures ("Braemar"). While at Braemar, Dr. Ma led investments in more than 15 companies involved in either resource efficiency, e-mobility, industrial digitalization, renewable energy, or deep tech, and has achieved multiple successful exits through M&A and IPO. Dr. Ma has significant knowledge and expertise in the technology industry, including information security. Prior to Braemar Energy Ventures, she was with the Venture Capital Group at 3i Group, a global private equity firm, where she led investments across multiple stages in Digital Health, TMT and Cleantech. Preceding the Venture Capital Group at 3i, Dr. Ma held several senior positions at Lucent Technologies and Bell Labs. Her responsibilities included lead roles in product portfolio strategy, new product launches for Optical and Data Networking, and research and product development. Dr. Ma was also a founding team member of Onetta Inc., a fiber networks company. She has a PhD in Electrical and Computer Engineering from the University Colorado at Boulder and an MS in Electrical Engineering from Worcester Polytechnic Institute. Dr. Ma is a Kauffman Fellow.- Jiong Ma自2021年3月起担任我们的首席执行官兼总裁。自2020年11月以来，马博士一直是Braemar Energy Ventures“；Braemar”；（一家专注于能源的风险投资公司）的风险合伙人。从2008年到2020年10月，马博士担任Braemar的高级合伙人和投资委员会成员。在Braemar任职期间，马云带领投资了超过15家涉及资源效率、电子移动、工业数字化、可再生能源或深度科技的公司，并通过并购和IPO实现了多次成功退出。在她的职业生涯中，她在10多家风险投资公司的董事会任职，包括Powervation（被Rohm Semiconductor Ltd.收购）、Convery Computer（被美光科技公司收购）、MC10（被Medidata收购）和Carbonite Inc.，该公司于2011年上市，随后于2019年被OpenText（NASDAQ:OTEX）以14.5亿美元收购。马博士目前在Anavex Life SciencesCorp.（NASDAQ:AVXL）的董事会任职，并担任DeMeter Partners的顾问委员会成员，DeMeter Partners是一家致力于欧洲生态和能源转型的VC/PE基金，以及国家可再生能源实验室，美国能源部的一个国家实验室，负责开发转换能源的产生、消耗、储存和分配的解决方案。从2004年到2008年，马博士是3i（一家全球私人股本公司）风险投资部门的投资专家，在那里她领导了技术和媒体、数字健康和清洁技术的多个阶段的投资。从1997年到2004年，她在Lucent Technologies和Nortel Networks担任多个高级职位，在那里她负责投资组合战略、产品开发和研究与开发。2000年，马博士联合创立了Onetta Inc.，这是一家光学网络公司，该公司于2004年被Bookham Technology收购。马博士拥有科罗拉多大学博尔德分校电气和计算机工程博士学位，沃切斯特理工学院电气工程硕士学位，中国兰州大学物理和电气工程学士学位。马博士也是考夫曼的研究员。
- Jiong Ma,has over 25 years of experience in the investing, building and scaling of companies with a focus on innovative product launches in digital health, technology and the new energy transition. Dr. Ma currently serves on the board of SES AI Corporation (NYSE: SES), and LinkinVax, a biotech company, spin-off from the Vaccine Research Institute in France. Dr. Ma served as senior partner and a member of the investment committee at Braemar Energy Ventures ("Braemar"). While at Braemar, Dr. Ma led investments in more than 15 companies involved in either resource efficiency, e-mobility, industrial digitalization, renewable energy, or deep tech, and has achieved multiple successful exits through M&A and IPO. Dr. Ma has significant knowledge and expertise in the technology industry, including information security. Prior to Braemar Energy Ventures, she was with the Venture Capital Group at 3i Group, a global private equity firm, where she led investments across multiple stages in Digital Health, TMT and Cleantech. Preceding the Venture Capital Group at 3i, Dr. Ma held several senior positions at Lucent Technologies and Bell Labs. Her responsibilities included lead roles in product portfolio strategy, new product launches for Optical and Data Networking, and research and product development. Dr. Ma was also a founding team member of Onetta Inc., a fiber networks company. She has a PhD in Electrical and Computer Engineering from the University Colorado at Boulder and an MS in Electrical Engineering from Worcester Polytechnic Institute. Dr. Ma is a Kauffman Fellow.
- Michael Lee
Michael Lee自2021年3月起担任我们的首席财务官。李先生在私人股本和金融领域拥有超过22年的经验。他目前是New Highland LLC的管理成员，该公司是一家初创企业的财务咨询公司，他于2013年加入该公司。此前，从2001年到2013年，他曾担任Lincolnshire Management（一家私人股本公司）的董事，在那里他管理收购和企业资产剥离，并担任投资组合公司的高管和董事会成员。Lee先生的职业生涯始于瓦乔维亚银行的商业银行部门。他以优异成绩获得普林斯顿大学经济学学士学位。
Michael Lee has been our Chief Financial Officer since March 2021. Mr. Lee has over 22 years of experience in private equity and finance. He is currently the managing member of New Highland LLC, a finance consultancy for start-ups which he joined in 2013. Previously, from 2001 to 2013 Mr. Lee was a Director at Lincolnshire Management, a private equity firm, where he managed acquisitions and corporate divestitures and served in officer and board member roles of portfolio companies. Mr. Lee started his career at the merchant banking division of Wachovia Bank. He received a BA in Economics, magna cum laude, from Princeton University.- Michael Lee自2021年3月起担任我们的首席财务官。李先生在私人股本和金融领域拥有超过22年的经验。他目前是New Highland LLC的管理成员，该公司是一家初创企业的财务咨询公司，他于2013年加入该公司。此前，从2001年到2013年，他曾担任Lincolnshire Management（一家私人股本公司）的董事，在那里他管理收购和企业资产剥离，并担任投资组合公司的高管和董事会成员。Lee先生的职业生涯始于瓦乔维亚银行的商业银行部门。他以优异成绩获得普林斯顿大学经济学学士学位。
- Michael Lee has been our Chief Financial Officer since March 2021. Mr. Lee has over 22 years of experience in private equity and finance. He is currently the managing member of New Highland LLC, a finance consultancy for start-ups which he joined in 2013. Previously, from 2001 to 2013 Mr. Lee was a Director at Lincolnshire Management, a private equity firm, where he managed acquisitions and corporate divestitures and served in officer and board member roles of portfolio companies. Mr. Lee started his career at the merchant banking division of Wachovia Bank. He received a BA in Economics, magna cum laude, from Princeton University.